Solutions for various industries
Novasign Studio adapts to the process development context your team works in, whether you are a CDMO delivering to sponsors, a biopharma team building platform knowledge, or an industrial biotech company scaling toward production.
Choose your starting point
- CDMOsDeliver faster, more defensible process decisions.Novasign Studio helps CDMO process development teams turn process data, experimental results, expertise and models into structured, reusable workflows across upstream and downstream development.Explore solution for CDMOs
- BiopharmaStop running experiments you have already run.Novasign Studio helps biopharma process development teams turn historical data, existing models and scientific expertise into reproducible workflows across molecules, platforms and development stages. Fewer experiments, faster decisions, and scale-up confidence built on what you already have.Explore solution for biopharma
- Industrial biotechReach viable unit economics faster and scale with confidence.Novasign Studio helps industrial biotech, precision fermentation and cultured food teams reduce iteration cycles, identify the cost-critical process variables, and make confident scale-up decisions, from campaign history to cost-down clarity.Explore solution for industrial biotech
Benefits of Novasign Studio across industries
Outcomes of published studies in CDMOs, industrial biotech and biopharma, each reported against the partner’s own baseline and documented in a case study.
- CDMOsBespark*bio
8 runs instead of 22, 64% less experimental effort
A model trained on the reduced campaign (8 runs instead of 22) made the same decisions for optimizing a viral-vector process as one trained on the full campaign.
Read the Bespark*bio study - Industrial biotechBisy
2.4×
Bisy GmbH increased the enzymatic activity of a Komagataella phaffii enzyme process 2.4-fold.
Read the Bisy study - Industrial biotechArkeon
5.3×
Arkeon raised its specific yield 5.3-fold at 150 L over its initial process.
Read the Arkeon study - BiopharmaRepligen
5 experiments
A design space for glycoform and glycation, mapped from five experiments with Repligen’s PAT integrated.
Read the Repligen study - BiopharmaECONTI
Model-based control
In the ECONTI research consortium, Novasign’s models predicted and the automation platform decided and acted, over continuous operation of up to 30 days.
Read the ECONTI study
FAQ
The FAQ page answers how Novasign Studio applies to your process, how to get started and how many experiments you can save.
Not sure which solution fits your team?
30 minutes on your own campaign data, no qualification step. We help you find the right starting point for your process, your team and your data, before anything is committed.